Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia
Summary— A single causative mechanism for development of hypoglycemia unawareness in insulin‐dependent diabetes mellitus (IDDM) is not yet apparent. Reduced adrenergic sensitivity may be part of the explanation. This study was carried out to investigate the effect of hypoglycemia on β‐adrenergic sen...
Published in: | Fundamental & Clinical Pharmacology |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Wiley
1995
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1111/j.1472-8206.1995.tb00279.x https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.1995.tb00279.x https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1472-8206.1995.tb00279.x |
id |
crwiley:10.1111/j.1472-8206.1995.tb00279.x |
---|---|
record_format |
openpolar |
spelling |
crwiley:10.1111/j.1472-8206.1995.tb00279.x 2024-06-02T08:15:20+00:00 Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia Trovik, TS Jæger, R. Jorde, R. Sager, G. 1995 http://dx.doi.org/10.1111/j.1472-8206.1995.tb00279.x https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.1995.tb00279.x https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1472-8206.1995.tb00279.x en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Fundamental & Clinical Pharmacology volume 9, issue 2, page 181-186 ISSN 0767-3981 1472-8206 journal-article 1995 crwiley https://doi.org/10.1111/j.1472-8206.1995.tb00279.x 2024-05-03T11:55:38Z Summary— A single causative mechanism for development of hypoglycemia unawareness in insulin‐dependent diabetes mellitus (IDDM) is not yet apparent. Reduced adrenergic sensitivity may be part of the explanation. This study was carried out to investigate the effect of hypoglycemia on β‐adrenergic sensitivity. Ten healthy male subjects (age 19–23 years) gave informed consent to take part in the study. They were hospitalized overnight at the University Hospital of Tromsø, Department of Clinical Research, on two occasions. Isoprenaline and metoprolol sensitivity tests were performed the morning after hospitalization: once after an intravenous (iv) injection of placebo (0.9% NaCl), and once after an iv injection of insulin (0.15 IU insulin/kg body weight) to induce hypoglycemia. The dose of isoprenaline needed to increase heart rate (HR) by 25 beats per minute (bpm) (I 25 ), and the dose of metoprolol (M –12.5 ) needed to inhibit I 25 with 50% or 12.5 bpm, when injected simultaneously, were used as determinants of isoprenaline and metoprolol sensitivity. In this study, there was a significant ( p < 0.05) increase both in I 25 and M –12.5 after hypoglycemia. The dose‐response curve of isoprenaline/HR was significantly shifted to the right after hypoglycemia. This study shows that acute hypoglycemia induces a reduction in β‐adrenegic sensitivity, and it supports the hypothesis of reduced β‐adrenergic sensitivity as an important pathophysiological mechanism in hypoglycemia unawareness in IDDM. Article in Journal/Newspaper Tromsø Wiley Online Library Tromsø Fundamental & Clinical Pharmacology 9 2 181 186 |
institution |
Open Polar |
collection |
Wiley Online Library |
op_collection_id |
crwiley |
language |
English |
description |
Summary— A single causative mechanism for development of hypoglycemia unawareness in insulin‐dependent diabetes mellitus (IDDM) is not yet apparent. Reduced adrenergic sensitivity may be part of the explanation. This study was carried out to investigate the effect of hypoglycemia on β‐adrenergic sensitivity. Ten healthy male subjects (age 19–23 years) gave informed consent to take part in the study. They were hospitalized overnight at the University Hospital of Tromsø, Department of Clinical Research, on two occasions. Isoprenaline and metoprolol sensitivity tests were performed the morning after hospitalization: once after an intravenous (iv) injection of placebo (0.9% NaCl), and once after an iv injection of insulin (0.15 IU insulin/kg body weight) to induce hypoglycemia. The dose of isoprenaline needed to increase heart rate (HR) by 25 beats per minute (bpm) (I 25 ), and the dose of metoprolol (M –12.5 ) needed to inhibit I 25 with 50% or 12.5 bpm, when injected simultaneously, were used as determinants of isoprenaline and metoprolol sensitivity. In this study, there was a significant ( p < 0.05) increase both in I 25 and M –12.5 after hypoglycemia. The dose‐response curve of isoprenaline/HR was significantly shifted to the right after hypoglycemia. This study shows that acute hypoglycemia induces a reduction in β‐adrenegic sensitivity, and it supports the hypothesis of reduced β‐adrenergic sensitivity as an important pathophysiological mechanism in hypoglycemia unawareness in IDDM. |
format |
Article in Journal/Newspaper |
author |
Trovik, TS Jæger, R. Jorde, R. Sager, G. |
spellingShingle |
Trovik, TS Jæger, R. Jorde, R. Sager, G. Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
author_facet |
Trovik, TS Jæger, R. Jorde, R. Sager, G. |
author_sort |
Trovik, TS |
title |
Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
title_short |
Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
title_full |
Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
title_fullStr |
Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
title_full_unstemmed |
Reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
title_sort |
reduced β‐adrenergic sensitivity in healthy volunteers induced by hypoglycemia |
publisher |
Wiley |
publishDate |
1995 |
url |
http://dx.doi.org/10.1111/j.1472-8206.1995.tb00279.x https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.1995.tb00279.x https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1472-8206.1995.tb00279.x |
geographic |
Tromsø |
geographic_facet |
Tromsø |
genre |
Tromsø |
genre_facet |
Tromsø |
op_source |
Fundamental & Clinical Pharmacology volume 9, issue 2, page 181-186 ISSN 0767-3981 1472-8206 |
op_rights |
http://onlinelibrary.wiley.com/termsAndConditions#vor |
op_doi |
https://doi.org/10.1111/j.1472-8206.1995.tb00279.x |
container_title |
Fundamental & Clinical Pharmacology |
container_volume |
9 |
container_issue |
2 |
container_start_page |
181 |
op_container_end_page |
186 |
_version_ |
1800739481973686272 |